Naltrexone SR/Bupropion SR Therapy Reduced Body Weight and HgbA1C in Overweight/Obese Women with Type 2 Diabetes. American Diabetes Association, 2011.
P Hollander, J Loper, L Mignon, C Burns, R Harris-Collzao, D Kim.
Drug Treatment following a VLCD (Very Low Energy Diet). Obesity, Research Journal, 2010
Loper J, RA Lutes, JT Broyles, EJ Baltes, RK May.
Completed Research: A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Two Doses of Naltrexone Sustained Release, SR/Buproprion and Placebo in Obese Subjects. 2007-2009.
Clinical Experience in a Comprehensive Weight-Management Center in the Management of Eating Disorders and Obesity, Humana Press, 2005
J Loper, RA Lutes, Edited by DJ Goldstein.
Very Low Calorie Diets in the 21st Century, ADA Weight Management Newsletter, 2004.
J Loper.
Completed Research: Effects of VLCD and Drug Treatment for Obesity. Phen/Fen. Phentermine/Sibutramine.
VLCD followed by use of Phentermine for Weight Maintenance. Obesity Research Vol 8, 2000.
J Loper, R Lutes, JT Broyles, RK May, EJ Baltes.
Two-Year Maintenance Results of Combination Anti-Obesity Drugs Following Very Low Calorie Diet, Obesity Research Vol 5, 1997.
J Loper, JF, R Lutes, EJ Baltes, RK May, JT Broyles, RA Heuberger, RL Atkinson.
Combined Drug Treatment of Obesity. Obesity Research. 1995.
Atinkson, RL, RC Blank, JF Loper, D Schumacher, RA Lutes.
VLCD Followed by Combination Obesity Drugs: Results at One Year. Obesity Research 3. p 405. 1995.
RA Heuberger, J Loper, EJ Baltes, R Lutes, RK May, JT Broyles, RL Atkinson.